News

Collecting PK data in late phase trials led to alleviating additional trials, drug approval, and better dosing.

ACT December 2011 BPA Statement

Over the past year and a half we have been monitoring the trend towards adoption of risk-based monitoring across the industry, and in particular the move towards reduced source document verification (SDV).

GLOBAL TRIALS : Is Guatemala the Next Research Hotspot? SITES : Trials in Limited Resource Settings Also in this issue : New User Fees, Declining European Trials, Low Trial Results Reporting, Risk-Based Approach to Monitoring

The responsibilities regarding CV safety for drug developers are constantly evolving.

Tufts Center for Drug Development

Often CNS trial subjects face unique obstacles like mental dependency

Examining the challenges and solutions to the implementation of trials in resource-limited settings.

A case study of how cardiac safety assessments can be enhanced with Holter Bin.